"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.
DOSAGE AND ADMINISTRATION
For topical use only. LUZU Cream, 1% is not for ophthalmic, oral, or intravaginal use.
- When treating interdigital tinea pedis, a thin layer of LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for two (2) weeks.
- When treating tinea cruris or tinea corporis, LUZU Cream, 1% should be applied to the affected area and approximately 1 inch of the immediate surrounding area(s) once daily for one (1) week.
Dosage Forms And Strengths
Cream, 1%. Each gram of LUZU Cream, 1% contains 10 mg of luliconazole in a white cream base.
Storage And Handling
LUZU (luliconazole) Cream, 1% is a white cream supplied in tubes as follows:
30 g (NDC 99207-850-30)
60 g (NDC 99207-850-60)
Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C -to 30°C (59°F to 86°F) [see USP Controlled Room temperature].
Manufactured for: Medicis, a division of Valeant Pharmaceuticals, Bridgewater, NJ 08807 Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215. Product of Japan. Revised: 11/2013.
Last reviewed on RxList: 11/27/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Luzu Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.